Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever.

Autor: Rowaiye AB; National Biotechnology Development Agency, Abuja, Nigeria., Nwonu EJ; National Biotechnology Development Agency, Abuja, Nigeria., Asala TM; National Biotechnology Development Agency, Abuja, Nigeria., Ogu AC; National Biotechnology Development Agency, Abuja, Nigeria., Bur D; National Biotechnology Development Agency, Abuja, Nigeria., Chukwu C; National Biotechnology Development Agency, Abuja, Nigeria., Oli AN; Department of Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Nigeria., Agbalalah T; National Biotechnology Development Agency, Abuja, Nigeria.; Department of Anatomy, Baze University, Abuja, Nigeria.

Publikováno v: Clinical and experimental vaccine research [Clin Exp Vaccine Res] 2022 Sep; Vol. 11 (3), pp. 249-263. Date of Electronic Publication: 2022 Sep 30.